HealthCo reaffirms upgraded FY22 FFO and PDS DPU guidance

HealthCo (ASX: HCW) is pleased to reaffirm upgraded FY22 FFO and PDS DPU guidance with its FY22 Half Year results. 
 
Senior Portfolio Manager, Sam Morris said, “We are excited to deliver a strong result following the listing in Sep-21 with HCW’s high quality and diversified portfolio delivering against our core objective to provide unitholders with consistent and growing distributions.”
 
“We are making good progress unlocking the significant growth opportunity embedded in our development pipeline which will transform the scale and quality of the portfolio on completion. Construction of the 78 bed paediatric hospital at Camden is running over 4 weeks ahead of schedule and our EOI process for Stage 2 generated strong interest from leading national private hospital operators.”